Cargando…

Editorial: Opportunities for PET imaging for the identification, staging, and monitoring of cancers

Detalles Bibliográficos
Autores principales:	Sun, Jing, Sun, Zhi Yuan, Zhang, Long Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904280/ https://www.ncbi.nlm.nih.gov/pubmed/36761979 http://dx.doi.org/10.3389/fonc.2023.1135928

Ejemplares similares

Editorial: Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment
por: Ilhan, Harun, et al.
Publicado: (2022)

Editorial: Innovations in Imaging for Early Diagnosis and Monitoring for Patients With Gastrointestinal Cancer
por: Pandol, Stephen J., et al.
Publicado: (2022)

Editorial: Challenges and opportunities of TKIs in the treatment of NSCLC patients with uncommon mutations
por: Su, Chunxia, et al.
Publicado: (2022)

Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer
por: Von Rueden, Samantha K., et al.
Publicado: (2021)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Editorial: Cellular stress in blood cancer: Pathophysiology and therapeutic opportunities
por: Costoya, José A., et al.
Publicado: (2022)

Editorial: Emerging Translational Opportunities in Comparative Oncology with Companion Canine Cancers
por: Dewhirst, Mark W., et al.
Publicado: (2020)

(18)F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer
por: Wang, Jie, et al.
Publicado: (2023)

PSMA PET in Imaging Prostate Cancer
por: Tsechelidis, Ioannis, et al.
Publicado: (2022)

Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy
por: Jin, Jing, et al.
Publicado: (2019)

Editorial: Clinicopathological factors and staging in gastrointestinal cancers
por: Deshpande, Ravindra
Publicado: (2023)

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges
por: Hu, Qiuyuan, et al.
Publicado: (2023)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Editorial: Next generation staging in head and neck cancers
por: Iyer, N. Gopalakrishna, et al.
Publicado: (2022)

Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
por: Feng, Pengyang, et al.
Publicado: (2022)

Editorial: Optical Molecular Imaging in Cancer Research
por: Zhang, Guanglei, et al.
Publicado: (2022)

FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
por: Huang, Rong, et al.
Publicado: (2022)

A machine learning-based PET/CT model for automatic diagnosis of early-stage lung cancer
por: Wang, Huoqiang, et al.
Publicado: (2023)

Editorial: Reviews in cancer imaging and image-directed interventions
por: Al-Kadi, Omar S., et al.
Publicado: (2023)

Editorial: Methods in cancer imaging and image-directed interventions
por: Nijkamp, Jasper, et al.
Publicado: (2023)

Editorial: Radiomics in prostate cancer imaging
por: Brunese, Luca, et al.
Publicado: (2022)

Application of a Novel (68)Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients
por: Miao, Haitao, et al.
Publicado: (2022)

Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
por: Ming, Yue, et al.
Publicado: (2020)

Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer
por: Wumener, Xieraili, et al.
Publicado: (2022)

(18)F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer
por: Liu, Qiufang, et al.
Publicado: (2021)

Dynamic PET/CT Imaging of (68)Ga-FAPI-04 in Chinese Subjects
por: Wang, Shuailiang, et al.
Publicado: (2021)

UPS: Opportunities and challenges for gastric cancer treatment
por: Yang, Hang, et al.
Publicado: (2023)

Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management
por: Ahmed, Fatma, et al.
Publicado: (2016)

Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT
por: Zhou, Nina, et al.
Publicado: (2021)

Editorial: Identification of novel biomarkers for pancreatic and hepatocellular cancers
por: Matteucci, Laura, et al.
Publicado: (2022)

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021)

Significance of PET-CT for Detecting Occult Lymph Node Metastasis and Affecting Prognosis in Early-Stage Tongue Squamous Cell Carcinoma
por: Zhao, Guo, et al.
Publicado: (2020)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
por: Liu, Yao, et al.
Publicado: (2022)

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
por: Hu, Junjie, et al.
Publicado: (2021)

Editorial: Magnetic Resonance Imaging for Radiation Therapy
por: Wen, Ning, et al.
Publicado: (2020)

[(18)F]FET-PET Imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients – A Review
por: Götz, I., et al.
Publicado: (2013)

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging
por: Alhusaini, Saud, et al.
Publicado: (2023)

Editorial: Imaging in non-small cell lung cancer
por: Liu, Yiyan
Publicado: (2023)

Editorial: Imaging of bone cancers – novel methodologies and optimizations
por: Messina, Carmelo, et al.
Publicado: (2023)

Editorial: Recent advances of drug resistance research in colorectal cancer therapy
por: Ye, Chenyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_16qi4i11btgbdjmih5qul6u05c